The South African Health Products Regulatory Authority (SAHPRA) has approved Cipla’s latest first-line triple-combination antiretroviral (ARV) treatment for HIV.
Continue reading…
New drug approved:- Cipla’s new triple-combination antiretroviral drug approved
Posted on Leave a comment
A first for South Africa:- Biosimilar oncology drug authorised for use
Posted on Leave a comment
Cipla, South Africa’s third-largest pharmaceutical manufacturer, in collaboration with Teva Pharmaceutical Industries Ltd, has announced the launch of the country’s first biosimilar for the oncology and haematology markets.
Continue reading…